US6890426B2 - Magnetic separation apparatus and methods - Google Patents

Magnetic separation apparatus and methods Download PDF

Info

Publication number
US6890426B2
US6890426B2 US10/733,829 US73382903A US6890426B2 US 6890426 B2 US6890426 B2 US 6890426B2 US 73382903 A US73382903 A US 73382903A US 6890426 B2 US6890426 B2 US 6890426B2
Authority
US
United States
Prior art keywords
chamber
collection
magnetic
cells
vessel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US10/733,829
Other versions
US20040118757A1 (en
Inventor
Leon W. M. M. Terstappen
Gerald Dolan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunivest Corp
Janssen Diagnostics LLC
Original Assignee
Immunivest Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/867,009 external-priority patent/US5985153A/en
Priority claimed from US09/201,603 external-priority patent/US6136182A/en
Priority claimed from PCT/US1999/028231 external-priority patent/WO2000032293A1/en
Priority claimed from US09/856,672 external-priority patent/US6660159B1/en
Priority claimed from US10/602,979 external-priority patent/US6790366B2/en
Assigned to IMMUNIVEST CORPORATION reassignment IMMUNIVEST CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DOLAN, GERALD, TERSTAPPEN, LEON W.M.M.
Priority to US10/733,829 priority Critical patent/US6890426B2/en
Application filed by Immunivest Corp filed Critical Immunivest Corp
Publication of US20040118757A1 publication Critical patent/US20040118757A1/en
Priority to PCT/US2004/031132 priority patent/WO2005061075A1/en
Application granted granted Critical
Publication of US6890426B2 publication Critical patent/US6890426B2/en
Priority to US11/447,562 priority patent/US7666308B2/en
Assigned to VERIDEX, LLC reassignment VERIDEX, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IMMUNICON CORP.
Assigned to JANSSEN DIAGNOSTICS, LLC reassignment JANSSEN DIAGNOSTICS, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: VERIDEX, LLC
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00Magnetic separation
    • B03C1/002High gradient magnetic separation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C2201/00Details of magnetic or electrostatic separation
    • B03C2201/18Magnetic separation whereby the particles are suspended in a liquid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B03SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03CMAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C2201/00Details of magnetic or electrostatic separation
    • B03C2201/26Details of magnetic or electrostatic separation for use in medical applications
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Definitions

  • the present invention relates to improved apparatus and methods for performing qualitative and quantitative analysis of microscopic biological specimens.
  • the invention relates to such apparatus and methods for isolating, collecting, immobilizing, and/or analyzing microscopic biological specimens or substances which are susceptible to immunospecific or non-specific binding with magnetic-responsive particles having a binding agent for producing magnetically-labeled species within a fluid medium.
  • terms such as “target entity” shall refer to such biological specimens or substances of investigational interest which are susceptible to such magnetic labeling.
  • U.S. Pat. No. 5,985,853 describes an apparatus and method wherein an external magnetic gradient is employed to attract magnetically labeled target entities present in a collection chamber to one of its surfaces, and where an internal magnetic gradient is employed to obtain precise alignment of those entities on that surface.
  • the movement of magnetically labeled biological entities to the collection surface is obtained by applying a vertical magnetic gradient to move the magnetically labeled biological entities to the collection surface.
  • the collection surface is provided with a ferromagnetic collection structure, such as plurality of ferromagnetic lines supported on an optically transparent surface.
  • the magnetically labeled biological entities are pulled sufficiently close to the surface by the externally applied gradient, they come under the influence of an intense local gradient produced by the ferromagnetic collection structure and are immobilized at positions laterally adjacent thereto.
  • the local gradient preferably exceeds adhesion forces which can hold the biological entities to the transparent surface after they collide with the surface.
  • the adhesiveness of the surface must be sufficiently weak to allow the horizontal magnetic force to move the magnetically labeled biological entities towards the ferromagnetic structures.
  • the smoothness and the hydrophobic or hydrophilic nature of the surface are factors that can influence the material chosen for the collection surface or the treatment of this surface to obtain a slippery surface.
  • FIG. 1A is a schematic diagram of a magnetic separator.
  • FIG. 1B is a diagram showing the magnetic field provided in the magnetic separator of FIG. 1 A.
  • FIGS. 2A-C are microphotographs of specimens collected in a magnetic separator.
  • FIGS. 3A-I are plan views of alternative ferromagnetic collection structures for use in a magnetic separator.
  • FIGS. 5A-B are histograms of fluorescence signals obtained from a magnetic separator ( 5 A) and from a flow cytometer ( 5 B) employed to quantify species in identical fluid samples.
  • FIG. 4 is a schematic diagram of an optical tracking and detection mechanism for analyzing species collected in a magnetic separator.
  • FIGS. 6A-6B are microphotographs of specimens collected in a magnetic separator.
  • FIGS. 7A and 7B are successive schematic diagrams sowing a method of charge-enhanced collection in a magnetic separator.
  • FIGS. 8A and 8B are respective cross-sectional and plan views of a combined ferromagnetic and electrically conductive collection structure for a magnetic separator.
  • FIGS. 9A-9C are successive schematic views showing a method of particle separation in a magnetic separator.
  • FIGS. 10A-10C are successive schematic views showing a method of measuring particle density in a fluid having an unknown particle density.
  • FIGS. 11A and 11B are sectional views of a separation vessel configured for multiple simultaneous analysis of fluids containing multiple target species at differing concentrations.
  • target entities such as cells are collected against a collection surface of a vessel without subsequent alignment adjacent to a ferromagnetic collection structure.
  • the collection surface is oriented perpendicular to a magnetic field gradient produced by external magnets.
  • magnetic nanoparticles and magnetically labeled biological entities are collected in a substantially homogeneous distribution on an optically transparent surface while non-selected entities remain below in the fluid medium. This result can be accomplished by placing a chamber in a gap between two magnets arranged as shown in FIG. 1A , such that the chamber's transparent collection surface is effectively perpendicular to a vertical field gradient generated by external magnets 3 .
  • the magnets 3 have a thickness of 3 mm, and are tapered toward a gap of 3 mm.
  • the magnets 3 are held in a yoke 1 , which rests atop a housing 2 .
  • a vessel support 4 holds the vessel 6 in a region between the magnets where the lines of magnetic force are directed substantially perpendicular to the collection surface 5 of the vessel 6 .
  • the collection surface of the vessel is preferably formed of a 0.1 mm thick polycarbonate member.
  • the collection surface is parallel to, and 2 mm below, the upper surface of the external magnets 3 .
  • the space between the inner, top surface edges of the magnets is 3 mm.
  • the taper angle of the magnets 3 and the width of the gap between the two magnets determine the magnitude of the applied magnetic field gradient and the preferable position of the collection surface of the vessel.
  • the field gradient produced by the magnets can be characterized as having a substantially uniform region, wherein the gradient field lines are substantially parallel, and fringing regions, wherein the gradient field lines diverge toward the magnets.
  • FIG. 1B shows mathematically approximated magnetic field gradient lines for such a magnet arrangement.
  • the magnetic field lines (not shown) are predominantly parallel to the chamber surface while the gradient lines are predominantly perpendicular to it.
  • the vessel is positioned to place the chamber in the uniform region such that there are substantially no transverse magnetic gradient components which would cause lateral transport of the magnetically labeled biological entities to the collection surface.
  • a chamber with inner dimensions of 2.5 mm height (z), 3 mm width (x) and 30 mm length (y) was filled with 225 ⁇ l of a solution containing 150 nm diameter magnetic beads and placed in between the magnets as illustrated in FIG. 1 A.
  • the magnetic beads moved to the collection surface and were distributed evenly.
  • the surface material can be selected or otherwise treated to have an adhesive attraction for the collected species.
  • horizontal drifting of the collected species due to any deviations in positioning the chamber of deviations from the desired perpendicular magnetic gradients in the “substantially uniform” region can be eliminated.
  • FIG. 3 illustrates an example of the use of the magnets and the chamber with no ferromagnetic structure on the collection surface to localize, differentiate and enumerate peripheral blood selected epithelial derived tumor cells.
  • the buffer containing the detergent was discarded and the vessel was taken out of the separator and the cells collected at the wall were resuspended in 200 ⁇ l of a buffer containing the UV excitable nucleic acid dye DAPI (Molecular Probes) and Cytokeratin monoclonal antibodies (identifying epithelial cells) labeled with the fluorochrome Cy3.
  • DAPI UV excitable nucleic acid dye
  • Cytokeratin monoclonal antibodies identifying epithelial cells labeled with the fluorochrome Cy3.
  • the cells were incubated for 15 minutes after which the vessel was placed in the separator. After 5 minutes the uncollected fraction containing excess reagents was discarded, the vessel was taken out of the separator and the collected cells were resuspended in 200 ⁇ l of an isotonic buffer. This solution was placed into a collection chamber and placed in the magnetic separator shown in FIG. 1 A.
  • FIG. 2 A The ferrofluid labeled cells and the free ferrofluid particles moved immediately to the collection surface and were evenly distributed along the surface as is shown in FIG. 2 A.
  • the figure shows a representative area on the collection surface using transmitted light and a 20 ⁇ objective.
  • FIG. 2B the same field is shown but now a filter cube is used for Cy3 excitation and emission. Two objects can be identified and are indicated with 1 and 2 .
  • FIG. 2C shows the same field but the filter cube is switched to one with an excitation and emission filter cube for DAPI.
  • the objects at position 1 and 2 both stain with DAPI as indicated at positions 3 and 5 confirm their identity as epithelial cells. Additional non epithelial cells and other cell elements cells are identified by the DAPI stain; an example is indicated by the number 4.
  • a ferromagnetic collection structure can be provided on the collection surface of the vessel, in order to produce an intense local magnetic gradient for immobilizing the target entities laterally adjacent to the structures.
  • the various ferromagnetic structures described below have been made by standard lithographic techniques using Nickel (Ni) or Permalloy (Ni—Fe alloy).
  • the thickness of the evaporated metal layers was varied between 10 nm to 1700 nm.
  • the 10 nm structures were partially transparent. The immobilizing force of these thin structures was, however, considerably less than those in the 200-700 nm thickness range.
  • FIGS. 3A through 3I show various magnets for ferromagnetic collection structures.
  • the ferromagnetic collection structure comprises Ni wires with a spacing comparable to the cell diameter (nominally 10 microns).
  • a decrease in the spacing between the wires shown in FIG. 3C produces a much more uniform cell position relative to the wire edge. Almost all cells appear to be centrally aligned. However, a portion of each cell overlaps, and is obscured by the Ni wire.
  • Cells collected along the ferromagnetic collection structures can be detected by an automated optical tracking and detection system.
  • the tracking and detection system shown in FIG. 4 , employs a computer controlled motorized stage to move the magnets and chamber in the X and Y directions under a laser beam having an elliptical 2-15 ⁇ m spot.
  • the maximum speed of the table is 2 cm/sec in the Y direction, and 1 mm/sec in the X direction.
  • Two cylindrical lenses (1) and (2) and a position adjustable objective ( 3 ) taken from a Sony Compact Disk player were used to make a 2 ⁇ 15 ⁇ m elliptical spot on the sample with a 635 nm laser diode ( 4 ) as a light source (see inset 5 ).
  • the light reflected from the sample was projected on a photomultiplier ( 6 ) through a dichroic mirror ( 7 ), a spherical lens ( 8 ), a diaphragm ( 9 ) and band pass filters ( 10 ).
  • Measurement of differences in the polarization direction of the light reflected from the wires and projected on a quadrant photodiode ( 11 ) through the mirror ( 12 ), the dichroic mirror ( 7 ), a quarter-wavelength plate ( 13 ), a polarized beam splitter ( 14 ), a cylindrical lens ( 15 ) and a spherical lens ( 16 ) were used to determine the position of the laser spot on the sample and to feed back a signal to the objective ( 3 ) to correct its position for any deviations (see insert 17 ).
  • a photodiode ( 18 ) was positioned perpendicular to the sample and was used to measure light scattered from the illuminated events.
  • the feedback mechanism of the tracking system were optimized such that the laser beam kept the same X and Z position with respect to the lines while scanning in the Y direction with speeds up to 1 cm/sec. At the end of the 2 cm long line the position of the objective was changed to the next line, this was repeated until all the lines of the chamber were scanned.
  • polystyrene beads were prepared which were conjugated to ferrofluid as well as to four different amounts of the fluorochrome Cy5.
  • the beads were used at a concentration of 10 5 ml ⁇ 1 placed into a chamber with ferromagnetic collection structures of the type illustrated in FIG. 3 C.
  • the chamber was placed in the uniform gradient region between the two magnets and all beads aligned between the lines.
  • the tracking and detection system was used to measure the fluorescence signals obtained while scanning along the ferromagnetic wires.
  • FIG. 5A shows a histogram of the fluorescence signals of the bead mixture.
  • the collection structure can be configured to have a non-uniform geometry in order to centrally-align cells or other species of differing sizes.
  • FIG. 3D An example of such a structure is shown in FIG. 3D.
  • a collection structure pattern was made with one area of the collection surface having wires with a period of 10 ⁇ m and a spacing of 7 ⁇ m, and another area having wires with a period of 25 ⁇ m and a spacing of 7 ⁇ m. This was used to collect both the small platelets and the larger leukocytes from whole blood. Before collection, the blood was incubated with ferrofluid specific for platelets and leukocytes from whole blood.
  • ferrofluids specific for platelets and leukocytes i.e. a ferrofluid labeled with the monoclonal CD41 and a ferrofluid labeled with the monoclonal antibody CD45 respectively.
  • the leukocytes and platelets align along the wires in the respective areas of the collection surface as is illustrated in FIG. 3 D.
  • the measurement of the platelets can be performed at the area with the small spaces between the wires and the measurement of the leukocytes can be performed at the area with the larger spaces between the wires.
  • the variation of gap width along the length of the ferromagnetic structure provides linear alignment of the collected cells of different sizes along a common central axis.
  • FIGS. 3E , 3 F, 3 G, 3 H and 31 show a similar wire spacing as shown in FIG. 3C , but the wires have lateral protrusions formed along the lengths thereof.
  • FIG. 3E shows a similar wire spacing as shown in FIG. 3C , but the wires have lateral protrusions formed along the lengths thereof.
  • FIG. 3E shows a similar wire spacing as shown in FIG. 3C , but the wires have lateral protrusions formed along the lengths thereof.
  • Such a design induces a periodic positioning of the cells in both axes of the collection plane.
  • FIG. 3F removes the slight (right-left) asymmetry observed in the FIG. 3 E.
  • Adding a larger asymmetric triangular “prong” edge shape as is illustrated in FIG. 3G is also effective for cells of varying sizes.
  • a sharper triangular style is illustrated in FIG. 3 H.
  • FIG. 31 shows an array of isolated rectangles, with their spacing along one axis set to match the cell size. The spacing along the other axis exceeds the cell size, so that cells move freely toward the positions between more closely-spaced sides of the rectangles.
  • Tumor derived epithelial cells can be detected in the peripheral blood and can be retrieved quantitatively from peripheral blood using anti-epithelial cell specific ferrofluids.
  • the physical appearance of the tumor derived epithelial cells is extremely heterogeneous ranging from 2-5 ⁇ m size apoptotic cells to tumor cell clumps of 100 ⁇ m size or more.
  • triangular shaped ferromagnetic structures as schematically illustrated in FIG. 3G or 3 H can be used.
  • An example of the positioning of peripheral blood derived cancer cells is illustrated in FIG. 6 .
  • FIG. 6A shows an area on the collection surface using transmitted light and a 20 ⁇ objective.
  • the ferromagnetic collection structure is indicated with 1 , the open wide collection space with 2 , the narrow collection space with 3 and a large object with 4 .
  • FIG. 6B shows the same area only now UV excitation is used.
  • the large object indeed is a large cell as confirmed by the staining with the nuclear dye indicator 5 and is nicely aligned.
  • the tracking system described in FIG. 4 was successfully used to scan along the ferromagnetic structures illustrated in FIGS. 3H and 6A .
  • ferromagnetic structures In addition to using ferromagnetic structures to create high local magnetic gradients, they also can serve as electronic conductors to apply local electronic field charges. Furthermore, electronic conductors can be formed on the collection surface to allow electronic manipulation of the collected target entities. The ability to first move biological entities to a specific location followed by an optical analysis is schematically illustrated in FIG. 7 A. Subsequent application of general or localized electronic charges, shown in FIG. 7B adds another dimension to the utility of the described system. Useful applications of local electronic charges for applications involving cells, RNA, protein and DNA are known. A schematic drawing of one design of such a collection surface is illustrated in FIG. 8 .
  • an optically transparent substrate 4 which provides an electronic circuit to the individual ferromagnetic structures, 5 in FIG. 8 B.
  • the next layer of Ni or other ferromagnetic material is evaporated onto the substrate, 2 in FIG. 8A , to create the individual ferromagnetic structures 5 in FIG. 8 B.
  • An insulating layer 3 can be obtained by the evaporation of SiO 2 or other insulating material. Magnetically labeled biological entities 7 localize in between the ferromagnetic structures.
  • Electronic charge can then be applied to improve the specificity of the immunospecific binding, change the orientation of the captured biological entity according to its electronic polarity, or to modify the entity properties (for example, to “explode” it) by applying an electronic charge to the conductors.
  • the biological entities can be studied before and/or after application of electronic charges.
  • the collection surface in the chambers has a limited capacity for capturing unbound excess magnetic particles, and these particles may interfere with the positioning and observation of the magnetically labeled biological entities.
  • An arrangement for separating unbound excess magnetic labeling particles form the magnetic labeled biological entities is illustrated in FIG. 9 .
  • the collection chamber comprises an outer compartment 1 and an inner compartment 2 .
  • the fluid sample containing unbound magnetic particles 3 and magnetically labeled and non-labeled biological entities 4 is placed in the inner compartment 2 .
  • At least one surface 5 of the inner chamber is porous, for example, a filter membrane having a pore size between 0.5 and 2 ⁇ m. Magnetic nanoparticles can pass through the pores, but the larger magnetically labeled cells cannot.
  • the opposite surface of the inner chamber 6 consists of a transparent surface with or without ferromagnetic collection structures as described above.
  • the outer chamber is filled with a buffer.
  • the vessel is then placed between the two magnets as shown in FIG. 9 B.
  • the chamber is positioned so that respective lateral portions of the vessel extend into the fringing magnetic gradient region.
  • the unbound magnetic particles are transported by the magnetic gradient through the membrane ( 5 ) and toward respective lateral regions 8 of the outer chamber ( 1 ). This movement is consistent with the magnetic gradient field lines shown in FIG. 1 B.
  • the lateral accumulation of the particles is effectively aided by the horizontal movement of those nanoparticles which first hit the surface and then slide along the slippery surface ( 7 ).
  • Magnetically labeled biological entities such as cells also move according to the gradient lines ( 9 ) until they reach the membrane, whereas non magnetic biological entities settle to the bottom under the influence of gravity.
  • the chamber is taken out of the magnetic separator and inverted ( 10 ).
  • the chamber is repositioned in the uniform gradient region to optimize the homogeneity of the distribution of the cells at the collection surface, FIG. 9 C.
  • the magnetically labeled cells move towards the optically transparent surface ( 6 ) (indicated with 11 in FIGS. 9B and 14 in FIG. 9C ) whereas the non magnetic biological entities settle to the membrane ( 5 ) under the influence of gravity.
  • the free magnetic nanoparticles move vertically toward the surface 6 .
  • the free magnetic nanoparticles are no longer present in the observation path and the magnetically labeled biological entities can be examined.
  • the system described above is especially suitable for applications in which the target cell number is low, in order to avoid clogging the membrane.
  • the height of the chamber in concert with the concentration of the target entity determines the density of the distribution of target entities collected at the collection surface of a vessel such as described above.
  • concentration may vary widely.
  • FIG. 10A a cross section of a chamber is shown with a collection surface 1 , and six compartments having different heights. Target cells are randomly positioned in the chamber.
  • FIG. 10B the same cross section is shown but now the cells have moved to the collection surface under the influence of the magnetic gradient.
  • chambers can be made with multiple compartments.
  • An example of such a chamber is illustrated in FIG. 11 A.
  • the collection surface 1 and two separate compartments 2 and 3 in these chambers permit the usage of a different set of reagents.
  • the reagents used will move all magnetically labeled cell types to the top.
  • An example is for instance the simultaneous use of a leukocyte specific and a platelet specific ferrofluid.
  • the density of the platelets is considerably larger than that of the leukocytes, measurement of the platelets would thus be done in the shallow part of the chamber (which may have a relatively small line spacing on the collection surface) and measurement of the leukocytes would be performed in the deeper part of the chamber (which may have a relatively larger line spacing on the collection surface; such as the arrangement shown in FIG. 3D. )

Abstract

Apparatuses and methods for separating, immobilizing, and quantifying biological substances from within a fluid medium. Biological substances are observed by employing a vessel (6) having a chamber therein, the vessel comprising a transparent collection wall (5). A high internal gradient magnetic capture structure may be on the transparent collection wall (5), magnets (3) create an externally-applied force for transporting magnetically responsive material toward the transparent collection wall (5). The magnetic capture structure comprises a plurality of ferromagnetic members and has a uniform or non-uniform spacing between adjacent members. There may be electrical conductor means supported on the transparent collection wall (5) for enabling electrical manipulation of the biological substances. The chamber has one compartment or a plurality of compartments with differing heights. The chamber may include a porous wall. The invention is also useful in conducting quantitative analysis and sample preparation in conjunction with automated cell enumeration techniques.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
This is a divisional of Ser. No. 10/602,979, filed on Jun. 24, 2003, now allowed, which is a division of Ser. No. 09/856,672, filed on May 24, 2001, now U.S. Pat. No. 6,660,159, which is a 371 of PCT/US99/28231, filed on Nov. 30, 1999, which is a continuation-in-part of U.S. application Ser. No. 09/201,603, filed Nov. 30, 1998, now U.S. Pat. No. 6,136,182 which is a continuation-in-part of U.S. application Ser. No. 08/867,009, filed Jun. 2, 1997, now U.S. Pat. No. 5,985,853, which claims the benefit of U.S. Provisional Application No. 60/019,282, filed Jun. 7, 1996, and claims the benefit of U.S. Provisional Application No. 60/030,436, filed Nov. 5, 1996. Application Ser. No. 09/856,672, now allowed, U.S. Pat. No. 6,136,182 and U.S. Pat. No. 5,985,853 are all incorporated in full by reference herein.
BACKGROUND
The present invention relates to improved apparatus and methods for performing qualitative and quantitative analysis of microscopic biological specimens. In particular, the invention relates to such apparatus and methods for isolating, collecting, immobilizing, and/or analyzing microscopic biological specimens or substances which are susceptible to immunospecific or non-specific binding with magnetic-responsive particles having a binding agent for producing magnetically-labeled species within a fluid medium. As used herein, terms such as “target entity” shall refer to such biological specimens or substances of investigational interest which are susceptible to such magnetic labeling.
U.S. Pat. No. 5,985,853 describes an apparatus and method wherein an external magnetic gradient is employed to attract magnetically labeled target entities present in a collection chamber to one of its surfaces, and where an internal magnetic gradient is employed to obtain precise alignment of those entities on that surface. The movement of magnetically labeled biological entities to the collection surface is obtained by applying a vertical magnetic gradient to move the magnetically labeled biological entities to the collection surface. The collection surface is provided with a ferromagnetic collection structure, such as plurality of ferromagnetic lines supported on an optically transparent surface.
Once the magnetically labeled biological entities are pulled sufficiently close to the surface by the externally applied gradient, they come under the influence of an intense local gradient produced by the ferromagnetic collection structure and are immobilized at positions laterally adjacent thereto. The local gradient preferably exceeds adhesion forces which can hold the biological entities to the transparent surface after they collide with the surface. Alternatively, the adhesiveness of the surface must be sufficiently weak to allow the horizontal magnetic force to move the magnetically labeled biological entities towards the ferromagnetic structures. The smoothness and the hydrophobic or hydrophilic nature of the surface are factors that can influence the material chosen for the collection surface or the treatment of this surface to obtain a slippery surface.
In accordance with the present invention, there are described further alternative embodiments and improvements for the collection chamber, the interior geometry of the collection chamber, and further useful techniques that may be accomplished by use of a vertical magnetic gradient separator structure.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1A is a schematic diagram of a magnetic separator.
FIG. 1B is a diagram showing the magnetic field provided in the magnetic separator of FIG. 1A.
FIGS. 2A-C are microphotographs of specimens collected in a magnetic separator.
FIGS. 3A-I are plan views of alternative ferromagnetic collection structures for use in a magnetic separator.
FIGS. 5A-B are histograms of fluorescence signals obtained from a magnetic separator (5A) and from a flow cytometer (5B) employed to quantify species in identical fluid samples.
FIG. 4 is a schematic diagram of an optical tracking and detection mechanism for analyzing species collected in a magnetic separator.
FIGS. 6A-6B are microphotographs of specimens collected in a magnetic separator.
FIGS. 7A and 7B are successive schematic diagrams sowing a method of charge-enhanced collection in a magnetic separator.
FIGS. 8A and 8B are respective cross-sectional and plan views of a combined ferromagnetic and electrically conductive collection structure for a magnetic separator.
FIGS. 9A-9C are successive schematic views showing a method of particle separation in a magnetic separator.
FIGS. 10A-10C are successive schematic views showing a method of measuring particle density in a fluid having an unknown particle density.
FIGS. 11A and 11B are sectional views of a separation vessel configured for multiple simultaneous analysis of fluids containing multiple target species at differing concentrations.
DETAILED DESCRIPTIONS
I. Vertical Gradient Collection and Observation of Target Entities
In a first embodiment of the invention, target entities such as cells are collected against a collection surface of a vessel without subsequent alignment adjacent to a ferromagnetic collection structure. The collection surface is oriented perpendicular to a magnetic field gradient produced by external magnets. In this embodiment, magnetic nanoparticles and magnetically labeled biological entities are collected in a substantially homogeneous distribution on an optically transparent surface while non-selected entities remain below in the fluid medium. This result can be accomplished by placing a chamber in a gap between two magnets arranged as shown in FIG. 1A, such that the chamber's transparent collection surface is effectively perpendicular to a vertical field gradient generated by external magnets 3. The magnets 3 have a thickness of 3 mm, and are tapered toward a gap of 3 mm. The magnets 3 are held in a yoke 1, which rests atop a housing 2. A vessel support 4 holds the vessel 6 in a region between the magnets where the lines of magnetic force are directed substantially perpendicular to the collection surface 5 of the vessel 6. The collection surface of the vessel is preferably formed of a 0.1 mm thick polycarbonate member. The collection surface is parallel to, and 2 mm below, the upper surface of the external magnets 3. The space between the inner, top surface edges of the magnets is 3 mm.
The taper angle of the magnets 3 and the width of the gap between the two magnets determine the magnitude of the applied magnetic field gradient and the preferable position of the collection surface of the vessel. The field gradient produced by the magnets can be characterized as having a substantially uniform region, wherein the gradient field lines are substantially parallel, and fringing regions, wherein the gradient field lines diverge toward the magnets. FIG. 1B shows mathematically approximated magnetic field gradient lines for such a magnet arrangement. The magnetic field lines (not shown) are predominantly parallel to the chamber surface while the gradient lines are predominantly perpendicular to it. To collect a uniformly distributed layer of the target entities, the vessel is positioned to place the chamber in the uniform region such that there are substantially no transverse magnetic gradient components which would cause lateral transport of the magnetically labeled biological entities to the collection surface.
To illustrate the collection pattern of magnetic material on the collection surface area, a chamber with inner dimensions of 2.5 mm height (z), 3 mm width (x) and 30 mm length (y) was filled with 225 μl of a solution containing 150 nm diameter magnetic beads and placed in between the magnets as illustrated in FIG. 1A. The magnetic beads moved to the collection surface and were distributed evenly. When the vessel was elevated relative to the magnets, such that a significant portion of the top of the vessel was positioned in a fringing region, significant quantities of the magnetic particles parallel toward and accumulated at respective lateral areas of the collection surface positioned nearest the magnets.
In order to enhance uniformity of collection on the collection surface, the surface material can be selected or otherwise treated to have an adhesive attraction for the collected species. In such an adhesive arrangement, horizontal drifting of the collected species due to any deviations in positioning the chamber of deviations from the desired perpendicular magnetic gradients in the “substantially uniform” region can be eliminated.
An example of the use of the present embodiment discussed device is a blood cancer test. Tumor derived epithelial cells can be detected in the peripheral blood. Although present at low densities, 1-1000 cells per 10 ml of blood, the cells can be retrieved and quantitatively analyzed from a sample of peripheral blood using an anti-epithelial cell specific ferrofluid. FIG. 3 illustrates an example of the use of the magnets and the chamber with no ferromagnetic structure on the collection surface to localize, differentiate and enumerate peripheral blood selected epithelial derived tumor cells. In this example, 5 ml of blood was incubated with 35 μg of an epithelial cell specific ferrofluid (EPCAM-FF, Immunicon Corp., Huntingdon Valley, Pa.) for 15 minutes. The sample was placed in a quadrupole magnetic separator (QMS 17, Immunicon Corp.) for 10 minutes and the blood was discarded. The vessel was taken out of the separator and the collected cells present at the wall of the separation vessel were resuspended in a 3 ml of a buffer containing a detergent to permeabilize the cells (Immunoperm, Immunicon Corp.) and placed back in the separator for 10 minutes. The buffer containing the detergent was discarded and the vessel was taken out of the separator and the cells collected at the wall were resuspended in 200 μl of a buffer containing the UV excitable nucleic acid dye DAPI (Molecular Probes) and Cytokeratin monoclonal antibodies (identifying epithelial cells) labeled with the fluorochrome Cy3. The cells were incubated for 15 minutes after which the vessel was placed in the separator. After 5 minutes the uncollected fraction containing excess reagents was discarded, the vessel was taken out of the separator and the collected cells were resuspended in 200 μl of an isotonic buffer. This solution was placed into a collection chamber and placed in the magnetic separator shown in FIG. 1A. The ferrofluid labeled cells and the free ferrofluid particles moved immediately to the collection surface and were evenly distributed along the surface as is shown in FIG. 2A. The figure shows a representative area on the collection surface using transmitted light and a 20× objective. In FIG. 2B the same field is shown but now a filter cube is used for Cy3 excitation and emission. Two objects can be identified and are indicated with 1 and 2. FIG. 2C shows the same field but the filter cube is switched to one with an excitation and emission filter cube for DAPI. The objects at position 1 and 2 both stain with DAPI as indicated at positions 3 and 5 confirm their identity as epithelial cells. Additional non epithelial cells and other cell elements cells are identified by the DAPI stain; an example is indicated by the number 4.
II. Ferromagnetic Collection Structures Producing Central Alignment of Cells
To provide for spatially patterned collection of target entities, a ferromagnetic collection structure can be provided on the collection surface of the vessel, in order to produce an intense local magnetic gradient for immobilizing the target entities laterally adjacent to the structures. The various ferromagnetic structures described below have been made by standard lithographic techniques using Nickel (Ni) or Permalloy (Ni—Fe alloy). The thickness of the evaporated metal layers was varied between 10 nm to 1700 nm. The 10 nm structures were partially transparent. The immobilizing force of these thin structures was, however, considerably less than those in the 200-700 nm thickness range. Although immobilization and alignment of magnetically labeled biological entities occurred sufficiently reliably, use of these moderately thicker structures was facilitated by a collection surface which had no or little adhesive force. Collection structures thicknesses between 200 and 1700 nm were effective in capturing the magnetically labeled biological entities and overcoming the surface adhesion.
FIGS. 3A through 3I show various magnets for ferromagnetic collection structures.
In FIG. 3B the ferromagnetic collection structure comprises Ni wires with a spacing comparable to the cell diameter (nominally 10 microns). A decrease in the spacing between the wires shown in FIG. 3C, produces a much more uniform cell position relative to the wire edge. Almost all cells appear to be centrally aligned. However, a portion of each cell overlaps, and is obscured by the Ni wire.
Cells collected along the ferromagnetic collection structures can be detected by an automated optical tracking and detection system. The tracking and detection system, shown in FIG. 4, employs a computer controlled motorized stage to move the magnets and chamber in the X and Y directions under a laser beam having an elliptical 2-15 μm spot. The maximum speed of the table is 2 cm/sec in the Y direction, and 1 mm/sec in the X direction. Two cylindrical lenses (1) and (2) and a position adjustable objective (3) taken from a Sony Compact Disk player were used to make a 2×15 μm elliptical spot on the sample with a 635 nm laser diode (4) as a light source (see inset 5). The light reflected from the sample was projected on a photomultiplier (6) through a dichroic mirror (7), a spherical lens (8), a diaphragm (9) and band pass filters (10). Measurement of differences in the polarization direction of the light reflected from the wires and projected on a quadrant photodiode (11) through the mirror (12), the dichroic mirror (7), a quarter-wavelength plate (13), a polarized beam splitter (14), a cylindrical lens (15) and a spherical lens (16) were used to determine the position of the laser spot on the sample and to feed back a signal to the objective (3) to correct its position for any deviations (see insert 17). A photodiode (18) was positioned perpendicular to the sample and was used to measure light scattered from the illuminated events. The feedback mechanism of the tracking system were optimized such that the laser beam kept the same X and Z position with respect to the lines while scanning in the Y direction with speeds up to 1 cm/sec. At the end of the 2 cm long line the position of the objective was changed to the next line, this was repeated until all the lines of the chamber were scanned.
To evaluate the performance of the tracking and detection system and compare it to that of a flow cytometer, 6 μm polystyrene beads were prepared which were conjugated to ferrofluid as well as to four different amounts of the fluorochrome Cy5. The beads were used at a concentration of 105 ml−1 placed into a chamber with ferromagnetic collection structures of the type illustrated in FIG. 3C. The chamber was placed in the uniform gradient region between the two magnets and all beads aligned between the lines. The tracking and detection system was used to measure the fluorescence signals obtained while scanning along the ferromagnetic wires. FIG. 5A shows a histogram of the fluorescence signals of the bead mixture. Four clearly resolved peaks are discernible representing the beads with no Cy5, dimly, intermediate and brightly labeled with Cy5. A mixture of the same beads was made and measured with a flow cytometer also equipped with a 635 nm laser diode (FACScalibur, BDIS, San Jose Calif.). The histogram of the fluorescence signals is shown in FIG. 5B and shows that although four different populations were discernible, they are clearly less resolved than in case samples, measured with the magnetic immobilization cytometer of the present invention. These results demonstrate that the alignment of the beads obtained with the system described herein provides a sensitivity and accuracy of the measurement of fluorescent beads which is superior to that of the flow cytometer.
In applications where it is desired to simultaneously measure biological entities with significant differences in size, the collection structure can be configured to have a non-uniform geometry in order to centrally-align cells or other species of differing sizes. An example of such a structure is shown in FIG. 3D. A collection structure pattern was made with one area of the collection surface having wires with a period of 10 μm and a spacing of 7 μm, and another area having wires with a period of 25 μm and a spacing of 7 μm. This was used to collect both the small platelets and the larger leukocytes from whole blood. Before collection, the blood was incubated with ferrofluid specific for platelets and leukocytes from whole blood. Before collection, the blood was incubated with ferrofluids specific for platelets and leukocytes i.e. a ferrofluid labeled with the monoclonal CD41 and a ferrofluid labeled with the monoclonal antibody CD45 respectively. The leukocytes and platelets align along the wires in the respective areas of the collection surface as is illustrated in FIG. 3D. The measurement of the platelets can be performed at the area with the small spaces between the wires and the measurement of the leukocytes can be performed at the area with the larger spaces between the wires. The variation of gap width along the length of the ferromagnetic structure provides linear alignment of the collected cells of different sizes along a common central axis.
Many more collection structure patterns are possible within the scope of the invention for capturing and centrally aligning cells of varying sizes in a single sample. Four examples are illustrated in FIGS. 3E, 3F, 3G, 3H and 31. FIG. 3E shows a similar wire spacing as shown in FIG. 3C, but the wires have lateral protrusions formed along the lengths thereof. For the geometry of FIG. 3E, there were two positions chosen by the cells—to the left or right of the protrusions as shown. Such a design induces a periodic positioning of the cells in both axes of the collection plane. Adding an asymmetric triangular “prong” edge shape instead of a “bar,” as illustrated in FIG. 3F removes the slight (right-left) asymmetry observed in the FIG. 3E. Adding a larger asymmetric triangular “prong” edge shape as is illustrated in FIG. 3G is also effective for cells of varying sizes. A sharper triangular style is illustrated in FIG. 3H. FIG. 31 shows an array of isolated rectangles, with their spacing along one axis set to match the cell size. The spacing along the other axis exceeds the cell size, so that cells move freely toward the positions between more closely-spaced sides of the rectangles.
An example of the utilization of custom designed ferromagnetic structure on the collection surface is a blood cancer test. Tumor derived epithelial cells can be detected in the peripheral blood and can be retrieved quantitatively from peripheral blood using anti-epithelial cell specific ferrofluids. The physical appearance of the tumor derived epithelial cells is extremely heterogeneous ranging from 2-5 μm size apoptotic cells to tumor cell clumps of 100 μm size or more. To accommodate this large range of sizes, triangular shaped ferromagnetic structures as schematically illustrated in FIG. 3G or 3H can be used. An example of the positioning of peripheral blood derived cancer cells is illustrated in FIG. 6. In this example, 5 ml of blood was incubated with epithelial cell specific ferrofluid (EPCAM-FF, Immunicon Corp.) and processed using the same method as described above. The final cell suspension was placed in the magnetic separator. The ferrofluid labeled cells and the free ferrofluid move immediately to the collection surface. FIG. 6A shows an area on the collection surface using transmitted light and a 20× objective. The ferromagnetic collection structure is indicated with 1, the open wide collection space with 2, the narrow collection space with 3 and a large object with 4. FIG. 6B shows the same area only now UV excitation is used. The large object indeed is a large cell as confirmed by the staining with the nuclear dye indicator 5 and is nicely aligned. The tracking system described in FIG. 4 was successfully used to scan along the ferromagnetic structures illustrated in FIGS. 3H and 6A.
III. Addressable Ferromagnetic Collection Structures
In addition to using ferromagnetic structures to create high local magnetic gradients, they also can serve as electronic conductors to apply local electronic field charges. Furthermore, electronic conductors can be formed on the collection surface to allow electronic manipulation of the collected target entities. The ability to first move biological entities to a specific location followed by an optical analysis is schematically illustrated in FIG. 7A. Subsequent application of general or localized electronic charges, shown in FIG. 7B adds another dimension to the utility of the described system. Useful applications of local electronic charges for applications involving cells, RNA, protein and DNA are known. A schematic drawing of one design of such a collection surface is illustrated in FIG. 8. To optimize the control over the electronic charge one can first evaporate a specific pattern/layers of Aluminum 1 onto an optically transparent substrate 4, which provides an electronic circuit to the individual ferromagnetic structures, 5 in FIG. 8B. The next layer of Ni or other ferromagnetic material is evaporated onto the substrate, 2 in FIG. 8A, to create the individual ferromagnetic structures 5 in FIG. 8B. An insulating layer 3 can be obtained by the evaporation of SiO2 or other insulating material. Magnetically labeled biological entities 7 localize in between the ferromagnetic structures. Electronic charge can then be applied to improve the specificity of the immunospecific binding, change the orientation of the captured biological entity according to its electronic polarity, or to modify the entity properties (for example, to “explode” it) by applying an electronic charge to the conductors. The biological entities can be studied before and/or after application of electronic charges.
IV. Porous Chamber Surfaces for Excess Particle Removal
When large initial volumes of fluid samples are processed and reduced to smaller volumes by magnetic separation, the concentration of the nanometer sized (<200 nm) magnetic labeling particles increases proportionally. The collection surface in the chambers has a limited capacity for capturing unbound excess magnetic particles, and these particles may interfere with the positioning and observation of the magnetically labeled biological entities. An arrangement for separating unbound excess magnetic labeling particles form the magnetic labeled biological entities is illustrated in FIG. 9. The collection chamber comprises an outer compartment 1 and an inner compartment 2. The fluid sample containing unbound magnetic particles 3 and magnetically labeled and non-labeled biological entities 4 is placed in the inner compartment 2. At least one surface 5 of the inner chamber is porous, for example, a filter membrane having a pore size between 0.5 and 2 μm. Magnetic nanoparticles can pass through the pores, but the larger magnetically labeled cells cannot. The opposite surface of the inner chamber 6 consists of a transparent surface with or without ferromagnetic collection structures as described above.
After the inner chamber is filled with the fluid sample, the outer chamber is filled with a buffer. The vessel is then placed between the two magnets as shown in FIG. 9B. The chamber is positioned so that respective lateral portions of the vessel extend into the fringing magnetic gradient region. The unbound magnetic particles are transported by the magnetic gradient through the membrane (5) and toward respective lateral regions 8 of the outer chamber (1). This movement is consistent with the magnetic gradient field lines shown in FIG. 1B. The lateral accumulation of the particles is effectively aided by the horizontal movement of those nanoparticles which first hit the surface and then slide along the slippery surface (7).
Magnetically labeled biological entities such as cells also move according to the gradient lines (9) until they reach the membrane, whereas non magnetic biological entities settle to the bottom under the influence of gravity. After the separation of unbound particles is complete, the chamber is taken out of the magnetic separator and inverted (10). The chamber is repositioned in the uniform gradient region to optimize the homogeneity of the distribution of the cells at the collection surface, FIG. 9C. The magnetically labeled cells move towards the optically transparent surface (6) (indicated with 11 in FIGS. 9B and 14 in FIG. 9C) whereas the non magnetic biological entities settle to the membrane (5) under the influence of gravity. The free magnetic nanoparticles move vertically toward the surface 6. The free magnetic nanoparticles are no longer present in the observation path and the magnetically labeled biological entities can be examined. The system described above is especially suitable for applications in which the target cell number is low, in order to avoid clogging the membrane.
V. Longitudinal Variation of Chamber Height
The height of the chamber in concert with the concentration of the target entity determines the density of the distribution of target entities collected at the collection surface of a vessel such as described above. To increase the range of surface collection densities which are acceptable for accurate counting and analysis, one can vary the height of the chamber to eliminate the need to dilute or concentrate the sample, for analysis of samples where the concentration may vary widely. In FIG. 10A, a cross section of a chamber is shown with a collection surface 1, and six compartments having different heights. Target cells are randomly positioned in the chamber. In FIG. 10B the same cross section is shown but now the cells have moved to the collection surface under the influence of the magnetic gradient. In the area of the highest chamber depth, the density of the cells is too high to be accurately measured, whereas in the area of the lowest chamber depth, too few cells are present to provide an accurate cell count. To further illustrate this principle, a histogram of the cell density along the collection surface is shown in FIG. 11C. Note that the number of cells in the area with the highest density is underestimated. The approach described here increases the range of concentrations which can be accurately measured as compared to the cell number measurements traditionally used in hematology analyzers and flow cytometers.
VI. Different Compartments in the Chamber
Different types of target entities present at different densities can be present in the sample. To permit simultaneous multiple analyses, chambers can be made with multiple compartments. An example of such a chamber is illustrated in FIG. 11A. The collection surface 1 and two separate compartments 2 and 3 in these chambers permit the usage of a different set of reagents. In case areas in the chamber are not separated by a wall, as illustrated with 4 in FIG. 11B, the reagents used will move all magnetically labeled cell types to the top. An example is for instance the simultaneous use of a leukocyte specific and a platelet specific ferrofluid. The density of the platelets is considerably larger than that of the leukocytes, measurement of the platelets would thus be done in the shallow part of the chamber (which may have a relatively small line spacing on the collection surface) and measurement of the leukocytes would be performed in the deeper part of the chamber (which may have a relatively larger line spacing on the collection surface; such as the arrangement shown in FIG. 3D.)
The terms and expressions which have been employed are used as terms of description and not of limitation. There is no intention in the use of such terms and expressions of excluding any equivalents of the features shown and described or any portions thereof. It is recognized, therefore, that various modifications are possible within the scope of the invention as claimed.

Claims (1)

1. An apparatus for observing magnetically responsive microscopic entities suspended in a fluid member, comprising:
a. a vessel having a transparent wall and a chamber formed therein for containing the fluid medium;
b. a ferromagnetic capture structure supported on the interior surface of the transparent wall;
c. magnetic means for inducing an internal magnetic gradient in the vicinity of the ferromagnetic capture structure, whereby the magnetically responsive entities are immobilized along the wall adjacent to the capture structure; and
d. electrical conductor means supported on the transparent wall for enabling electrical manipulation of the immobilized entities.
US10/733,829 1996-06-07 2003-12-10 Magnetic separation apparatus and methods Expired - Lifetime US6890426B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/733,829 US6890426B2 (en) 1996-06-07 2003-12-10 Magnetic separation apparatus and methods
PCT/US2004/031132 WO2005061075A1 (en) 2003-12-10 2004-09-22 Magnetic separation apparatus and methods
US11/447,562 US7666308B2 (en) 1996-06-07 2006-06-06 Magnetic separation apparatus and methods

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US1928296P 1996-06-07 1996-06-07
US3043696P 1996-11-05 1996-11-05
US08/867,009 US5985153A (en) 1996-06-07 1997-06-02 Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
US09/201,603 US6136182A (en) 1996-06-07 1998-11-30 Magnetic devices and sample chambers for examination and manipulation of cells
PCT/US1999/028231 WO2000032293A1 (en) 1998-11-30 1999-11-30 Magnetic separation apparatus and methods
US09/856,672 US6660159B1 (en) 1996-06-07 1999-11-30 Magnetic separation apparatus and methods
US10/602,979 US6790366B2 (en) 1996-06-07 2003-06-24 Magnetic separation apparatus and methods
US10/733,829 US6890426B2 (en) 1996-06-07 2003-12-10 Magnetic separation apparatus and methods

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/602,979 Division US6790366B2 (en) 1996-06-07 2003-06-24 Magnetic separation apparatus and methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/447,562 Continuation-In-Part US7666308B2 (en) 1996-06-07 2006-06-06 Magnetic separation apparatus and methods

Publications (2)

Publication Number Publication Date
US20040118757A1 US20040118757A1 (en) 2004-06-24
US6890426B2 true US6890426B2 (en) 2005-05-10

Family

ID=34710439

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/733,829 Expired - Lifetime US6890426B2 (en) 1996-06-07 2003-12-10 Magnetic separation apparatus and methods

Country Status (2)

Country Link
US (1) US6890426B2 (en)
WO (1) WO2005061075A1 (en)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257847A1 (en) * 1996-06-07 2006-11-16 Scholtens Tycho M Magnetic separation apparatus and methods
US20070117158A1 (en) * 2002-02-14 2007-05-24 Coumans Frank A Methods and algorithms for cell enumeration in a low-cost cytometer
US20070238169A1 (en) * 2006-04-11 2007-10-11 The Board Of Trustees Of The Leland Stanford Junior University Cell sorter and culture system
US20080261243A1 (en) * 2004-10-06 2008-10-23 Wellstat Biologics Corporation Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment
US20090167733A1 (en) * 2007-12-28 2009-07-02 Bong-Jun Lee Display substrate, method of manufacturing the display substrate and display apparatus having the display substrate
US20090220979A1 (en) * 2007-12-12 2009-09-03 The Board Of Trustees Of The Leland Stanford Junior University Methods and Apparatus for Magnetic Separation of Cells
WO2009120767A1 (en) 2008-03-25 2009-10-01 Veridex, Llc A method for detecting igf1r/chr 15 circulating tumor cells using fish
US7615382B2 (en) 2005-11-09 2009-11-10 The Board Of Trustees Of The Leland Stanford Junior University Magnetic sifter
US20090286264A1 (en) * 2008-05-19 2009-11-19 Scholtens Tyco M Imaging of immunomagnetically enriched rare cells
US20100120072A1 (en) * 2007-04-19 2010-05-13 Wellstat Biologics Corporation Detection of elevated levels of her-2/neu protein from non-isolated circulating cancer cells and treatment
US20110044527A1 (en) * 2002-02-14 2011-02-24 Veridex, Llc Methods and Algorithms for Cell Enumeration in a Low-Cost Cytometer
US20110052037A1 (en) * 2004-07-30 2011-03-03 Veridex, Llc Methods and Algorithms For Cell Enumeration in a Low-Cost Cytometer
WO2013016600A2 (en) 2011-07-28 2013-01-31 The Trustees Of The University Of Pennsylvania Methods and reagents for diagnosing conditions and characterization of tumor cells associated with serous fluids
US8710836B2 (en) 2008-12-10 2014-04-29 Nanomr, Inc. NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US20140295420A1 (en) * 2011-06-15 2014-10-02 Koninklijke Philips N.V. Processing of biological sample components
US8956536B2 (en) 2012-10-26 2015-02-17 Becton, Dickinson And Company Devices and methods for manipulating components in a fluid sample
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
US9389225B2 (en) 2010-04-21 2016-07-12 Dna Electronics, Inc. Separating target analytes using alternating magnetic fields
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9739714B2 (en) 2012-10-29 2017-08-22 Mbio Diagnostics, Inc. Particle identification system, cartridge and associated methods
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9885642B2 (en) 2011-04-27 2018-02-06 Becton, Dickinson And Company Devices and methods for separating magnetically labeled moieties in a sample
US9902949B2 (en) 2012-12-19 2018-02-27 Dnae Group Holdings Limited Methods for universal target capture
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US10088481B2 (en) 2009-04-16 2018-10-02 Diagnostic Hybrids, Inc. Methods for liquid direct fluorescent antibody intracellular virus detection
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
US10495644B2 (en) 2014-04-01 2019-12-03 Academia Sinica Methods and systems for cancer diagnosis and prognosis

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438385A1 (en) * 2001-10-25 2004-07-21 Bar-Ilan University Interactive transparent individual cells biochip processor
ES2375724T3 (en) 2002-09-27 2012-03-05 The General Hospital Corporation MICROFLUDE DEVICE FOR SEPERATION OF CELLS AND ITS USES.
IL154677A0 (en) * 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
US20060240548A1 (en) * 2003-06-26 2006-10-26 Mordechai Deutsch Materials for constructing cell-chips, cell-chip covers, cell-chips coats, processed cell-chips and uses thereof
US8597597B2 (en) * 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US7888110B2 (en) * 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
US20050266394A1 (en) * 2003-12-24 2005-12-01 Massachusette Institute Of Technology Magnetophoretic cell clarification
EP1781404A2 (en) * 2004-08-25 2007-05-09 Seng Enterprises Limited Method and device for isolating cells
US8038964B2 (en) * 2005-01-25 2011-10-18 Seng Enterprises Ltd. Device for studying individual cells
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
WO2007052245A1 (en) * 2005-11-03 2007-05-10 Seng Enterprises Ltd. Method and device for studying floating, living cells
US20080178692A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US20080241909A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Microfluidic chips for pathogen detection
US20080193919A1 (en) * 2005-11-30 2008-08-14 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and methods for receiving pathogen related information and responding
US20080210748A1 (en) 2005-11-30 2008-09-04 Searete Llc, A Limited Liability Corporation Of The State Of Delaware, Systems and methods for receiving pathogen related information and responding
US20080241935A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods for pathogen detection
US20080179255A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic devices
US20080241000A1 (en) * 2007-03-27 2008-10-02 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for pathogen detection
US8137912B2 (en) 2006-06-14 2012-03-20 The General Hospital Corporation Methods for the diagnosis of fetal abnormalities
EP2589668A1 (en) 2006-06-14 2013-05-08 Verinata Health, Inc Rare cell analysis using sample splitting and DNA tags
US20080050739A1 (en) 2006-06-14 2008-02-28 Roland Stoughton Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
EP2029779A4 (en) 2006-06-14 2010-01-20 Living Microsystems Inc Use of highly parallel snp genotyping for fetal diagnosis
US20080245740A1 (en) * 2007-01-29 2008-10-09 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Fluidic methods
US10001496B2 (en) * 2007-01-29 2018-06-19 Gearbox, Llc Systems for allergen detection
US20080181816A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Systems for allergen detection
US20080180259A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Devices for allergen detection
US20080181821A1 (en) * 2007-01-29 2008-07-31 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Microfluidic chips for allergen detection
US8617903B2 (en) * 2007-01-29 2013-12-31 The Invention Science Fund I, Llc Methods for allergen detection
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
WO2009081409A2 (en) 2007-12-26 2009-07-02 Seng Enterprises Ltd. Device for the study of living cells
EP3378951B1 (en) 2008-09-20 2020-05-13 The Board of Trustees of the Leland Stanford Junior University Noninvasive diagnosis of aneuploidy by sequencing
DK2440941T3 (en) 2009-06-10 2017-08-28 Cynvenio Biosystems Inc Sheath flow devices and methods
US9132389B2 (en) * 2011-08-08 2015-09-15 Colorado State University Research Foundation Magnetically responsive membranes
US20150064153A1 (en) 2013-03-15 2015-03-05 The Trustees Of Princeton University High efficiency microfluidic purification of stem cells to improve transplants
EP2971287B1 (en) 2013-03-15 2019-08-14 GPB Scientific, LLC On-chip microfluidic processing of particles
CN113512522A (en) 2013-03-15 2021-10-19 普林斯顿大学理事会 Method and apparatus for high throughput purification
US10976232B2 (en) 2015-08-24 2021-04-13 Gpb Scientific, Inc. Methods and devices for multi-step cell purification and concentration

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729949A (en) 1982-05-10 1988-03-08 Bar-Ilan University System and methods for cell selection
US4735504A (en) 1983-10-31 1988-04-05 Technicon Instruments Corporation Method and apparatus for determining the volume & index of refraction of particles
US4989978A (en) 1986-04-04 1991-02-05 Technicon Instruments Corporation Method and apparatus for determining the count per unit volume of particles
US5030560A (en) 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
US5053344A (en) 1987-08-04 1991-10-01 Cleveland Clinic Foundation Magnetic field separation and analysis system
US5089128A (en) 1988-05-25 1992-02-18 Ukrainsky Institute Inzhenerov Vodnogo Khozyaista Apparatus for separation of ferromagnetic materials from fluid media
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
WO1994011078A1 (en) 1992-11-16 1994-05-26 Immunivest Corporation Magnetic immobilization and manipulation of biological entities
US5340749A (en) 1988-04-26 1994-08-23 Nippon Telegraph And Telephone Corporation Method for collecting and preparing specimens for immune reactions
US5375606A (en) 1990-02-28 1994-12-27 Zynaxis, Inc. Bio-analytical separation method
US5411863A (en) 1988-12-28 1995-05-02 S. Miltenyi Methods and materials for improved high gradient magnetic separation of biological materials
US5428451A (en) 1989-12-07 1995-06-27 Diatec Instruments A/S Process and apparatus for counting particles
US5451525A (en) 1992-02-14 1995-09-19 Coulter Corporation Method and materials for determining particle count in a flow cytometer
US5466574A (en) 1991-03-25 1995-11-14 Immunivest Corporation Apparatus and methods for magnetic separation featuring external magnetic means
US5494831A (en) 1993-08-30 1996-02-27 Hughes Aircraft Company Electrochemical immunosensor system and methods
US5541072A (en) 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
WO1996026782A1 (en) 1995-02-27 1996-09-06 Miltenyi Biotech, Inc. Improved magnetic separation apparatus and method
US5985153A (en) 1996-06-07 1999-11-16 Immunivest Corporation Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
US6013532A (en) * 1990-09-26 2000-01-11 Immunivest Corporation Methods for magnetic immobilization and manipulation of cells
US6136182A (en) 1996-06-07 2000-10-24 Immunivest Corporation Magnetic devices and sample chambers for examination and manipulation of cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030344A (en) * 1989-07-24 1991-07-09 H.K. Research & Development, Inc. Magnetic fluid conditioner
US6790366B2 (en) * 1996-06-07 2004-09-14 Immunivest Corporation Magnetic separation apparatus and methods

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729949A (en) 1982-05-10 1988-03-08 Bar-Ilan University System and methods for cell selection
US4735504A (en) 1983-10-31 1988-04-05 Technicon Instruments Corporation Method and apparatus for determining the volume & index of refraction of particles
US4989978A (en) 1986-04-04 1991-02-05 Technicon Instruments Corporation Method and apparatus for determining the count per unit volume of particles
US5053344A (en) 1987-08-04 1991-10-01 Cleveland Clinic Foundation Magnetic field separation and analysis system
US5340749A (en) 1988-04-26 1994-08-23 Nippon Telegraph And Telephone Corporation Method for collecting and preparing specimens for immune reactions
US5498550A (en) 1988-04-26 1996-03-12 Nippon Telegraph & Telephone Corporation Device for collecting or preparing specimens using magnetic micro-particles
US5089128A (en) 1988-05-25 1992-02-18 Ukrainsky Institute Inzhenerov Vodnogo Khozyaista Apparatus for separation of ferromagnetic materials from fluid media
US5030560A (en) 1988-11-04 1991-07-09 Immucor, Inc. Method for drying mammalian cells for use in solid phase immunoassays and articles incorporating same
US5411863A (en) 1988-12-28 1995-05-02 S. Miltenyi Methods and materials for improved high gradient magnetic separation of biological materials
US5428451A (en) 1989-12-07 1995-06-27 Diatec Instruments A/S Process and apparatus for counting particles
US5375606A (en) 1990-02-28 1994-12-27 Zynaxis, Inc. Bio-analytical separation method
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US6013532A (en) * 1990-09-26 2000-01-11 Immunivest Corporation Methods for magnetic immobilization and manipulation of cells
US5466574A (en) 1991-03-25 1995-11-14 Immunivest Corporation Apparatus and methods for magnetic separation featuring external magnetic means
US5451525A (en) 1992-02-14 1995-09-19 Coulter Corporation Method and materials for determining particle count in a flow cytometer
WO1994011078A1 (en) 1992-11-16 1994-05-26 Immunivest Corporation Magnetic immobilization and manipulation of biological entities
US5494831A (en) 1993-08-30 1996-02-27 Hughes Aircraft Company Electrochemical immunosensor system and methods
US5541072A (en) 1994-04-18 1996-07-30 Immunivest Corporation Method for magnetic separation featuring magnetic particles in a multi-phase system
WO1996026782A1 (en) 1995-02-27 1996-09-06 Miltenyi Biotech, Inc. Improved magnetic separation apparatus and method
US5985153A (en) 1996-06-07 1999-11-16 Immunivest Corporation Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
US6136182A (en) 1996-06-07 2000-10-24 Immunivest Corporation Magnetic devices and sample chambers for examination and manipulation of cells

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
Ahn, et al., "A Fully Integrated Micromachined Magnetic Particle Manipulator and Separator", Proc. Workshop on Micro Electro Mechanical System IEEE, ISBN: 0-7803-1834-X, Jan. 25-28, 1994, pp. 91-96.
Chen et al., "Automated Enumeration of CD34+ Cells in Peripheral Blood and Bone Marrow", J. of Hematotherapy; 3:3-13 (1994).
deGroth et al., "The Cytodisk: A Cytometer Based Upon a New Principle of Cell Alignment", Cytometry; 6:226-233 (1995).
Kamentsky et al., "Microscope-Based Multiparameter Laser Scanning Cytometer Yielding Data Comparable to Flow Cytometry Data", Cytometry; 12:381-387 (1991).
Stewart, et al., "Quantitation of Cell Concentration Using the Flow Cytometer", Cytometry; 2:238-243 (1982).
Takayasu et al., "HGMS Studies of Blood Cell Behavior in Plasma", IEEE Transactions of Magnetics, 18:1520-1522 (1982).
Takayasu et al., "High Gradient Magnetic Separation II. Single Wire Studies of Shale Oils", IEEE Transactions on Magnetics; 18:1695-1697 (1982).
Zwerner et al., "A Whole Blood Alternative to Traditional Methods for CD4+ T Lymphocyte Determine" J. of Acquired Immune Deficiency Syndromes and Human Retrovirology; 14:31-34 (1997).

Cited By (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7666308B2 (en) * 1996-06-07 2010-02-23 Veridex, Llc. Magnetic separation apparatus and methods
US20060257847A1 (en) * 1996-06-07 2006-11-16 Scholtens Tycho M Magnetic separation apparatus and methods
US20070117158A1 (en) * 2002-02-14 2007-05-24 Coumans Frank A Methods and algorithms for cell enumeration in a low-cost cytometer
US8128890B2 (en) 2002-02-14 2012-03-06 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US20110044527A1 (en) * 2002-02-14 2011-02-24 Veridex, Llc Methods and Algorithms for Cell Enumeration in a Low-Cost Cytometer
US7764821B2 (en) 2002-02-14 2010-07-27 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US8189899B2 (en) 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
US20110052037A1 (en) * 2004-07-30 2011-03-03 Veridex, Llc Methods and Algorithms For Cell Enumeration in a Low-Cost Cytometer
US20080261243A1 (en) * 2004-10-06 2008-10-23 Wellstat Biologics Corporation Detection of Elevated Levels of Her-2/Neu Protein on Circulating Cancer Cells and Treatment
US20110070598A1 (en) * 2004-10-06 2011-03-24 Wellstat Biologics Corporation Detection of elevated levels of her-2/neu protein on circulating cancer cells and treatment
US7615382B2 (en) 2005-11-09 2009-11-10 The Board Of Trustees Of The Leland Stanford Junior University Magnetic sifter
US20070238169A1 (en) * 2006-04-11 2007-10-11 The Board Of Trustees Of The Leland Stanford Junior University Cell sorter and culture system
US20100120072A1 (en) * 2007-04-19 2010-05-13 Wellstat Biologics Corporation Detection of elevated levels of her-2/neu protein from non-isolated circulating cancer cells and treatment
US9267943B2 (en) 2007-12-12 2016-02-23 The Board Of Trustees Of The Leland Stanford Junior University Apparatus for magnetic separation of cells
US20090220979A1 (en) * 2007-12-12 2009-09-03 The Board Of Trustees Of The Leland Stanford Junior University Methods and Apparatus for Magnetic Separation of Cells
US8071395B2 (en) 2007-12-12 2011-12-06 The Board Of Trustees Of The Leland Stanford Junior University Methods and apparatus for magnetic separation of cells
US20090167733A1 (en) * 2007-12-28 2009-07-02 Bong-Jun Lee Display substrate, method of manufacturing the display substrate and display apparatus having the display substrate
US20090258365A1 (en) * 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
WO2009120767A1 (en) 2008-03-25 2009-10-01 Veridex, Llc A method for detecting igf1r/chr 15 circulating tumor cells using fish
US8569077B2 (en) 2008-05-19 2013-10-29 Veridex, Llc Imaging of immunomagnetically enriched rare cells
US20090286264A1 (en) * 2008-05-19 2009-11-19 Scholtens Tyco M Imaging of immunomagnetically enriched rare cells
US8710836B2 (en) 2008-12-10 2014-04-29 Nanomr, Inc. NMR, instrumentation, and flow meter/controller continuously detecting MR signals, from continuously flowing sample material
US10088481B2 (en) 2009-04-16 2018-10-02 Diagnostic Hybrids, Inc. Methods for liquid direct fluorescent antibody intracellular virus detection
US8790916B2 (en) 2009-05-14 2014-07-29 Genestream, Inc. Microfluidic method and system for isolating particles from biological fluid
US9128101B2 (en) 2010-03-01 2015-09-08 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
US11073513B2 (en) 2010-04-21 2021-07-27 Dnae Group Holdings Limited Separating target analytes using alternating magnetic fields
US9696302B2 (en) 2010-04-21 2017-07-04 Dnae Group Holdings Limited Methods for isolating a target analyte from a heterogeneous sample
US9389225B2 (en) 2010-04-21 2016-07-12 Dna Electronics, Inc. Separating target analytes using alternating magnetic fields
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US9869671B2 (en) 2010-04-21 2018-01-16 Dnae Group Holdings Limited Analyzing bacteria without culturing
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US10677789B2 (en) 2010-04-21 2020-06-09 Dnae Group Holdings Limited Analyzing bacteria without culturing
US9970931B2 (en) 2010-04-21 2018-05-15 Dnae Group Holdings Limited Methods for isolating a target analyte from a heterogenous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9562896B2 (en) 2010-04-21 2017-02-07 Dnae Group Holdings Limited Extracting low concentrations of bacteria from a sample
US11448646B2 (en) 2010-04-21 2022-09-20 Dnae Group Holdings Limited Isolating a target analyte from a body fluid
US9671395B2 (en) 2010-04-21 2017-06-06 Dnae Group Holdings Limited Analyzing bacteria without culturing
US10114020B2 (en) 2010-10-11 2018-10-30 Mbio Diagnostics, Inc. System and device for analyzing a fluidic sample
US10444125B2 (en) 2011-04-27 2019-10-15 Becton, Dickinson And Company Devices and methods for separating magnetically labeled moieties in a sample
US9885642B2 (en) 2011-04-27 2018-02-06 Becton, Dickinson And Company Devices and methods for separating magnetically labeled moieties in a sample
US20140295420A1 (en) * 2011-06-15 2014-10-02 Koninklijke Philips N.V. Processing of biological sample components
US9541480B2 (en) 2011-06-29 2017-01-10 Academia Sinica Capture, purification, and release of biological substances using a surface coating
US11674958B2 (en) 2011-06-29 2023-06-13 Academia Sinica Capture, purification, and release of biological substances using a surface coating
WO2013016600A2 (en) 2011-07-28 2013-01-31 The Trustees Of The University Of Pennsylvania Methods and reagents for diagnosing conditions and characterization of tumor cells associated with serous fluids
US9835540B2 (en) 2012-10-26 2017-12-05 Becton, Dickinson And Company Devices and methods for manipulating components in a fluid sample
US8956536B2 (en) 2012-10-26 2015-02-17 Becton, Dickinson And Company Devices and methods for manipulating components in a fluid sample
US9513205B2 (en) 2012-10-26 2016-12-06 Becton, Dickinson And Company Devices and methods for manipulating components in a fluid sample
US9739714B2 (en) 2012-10-29 2017-08-22 Mbio Diagnostics, Inc. Particle identification system, cartridge and associated methods
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US11603400B2 (en) 2012-12-19 2023-03-14 Dnae Group Holdings Limited Methods for raising antibodies
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US10379113B2 (en) 2012-12-19 2019-08-13 Dnae Group Holdings Limited Target detection
US10584329B2 (en) 2012-12-19 2020-03-10 Dnae Group Holdings Limited Methods for universal target capture
US9902949B2 (en) 2012-12-19 2018-02-27 Dnae Group Holdings Limited Methods for universal target capture
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
US10745763B2 (en) 2012-12-19 2020-08-18 Dnae Group Holdings Limited Target capture system
US11016086B2 (en) 2012-12-19 2021-05-25 Dnae Group Holdings Limited Sample entry
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US10495644B2 (en) 2014-04-01 2019-12-03 Academia Sinica Methods and systems for cancer diagnosis and prognosis
US10112198B2 (en) 2014-08-26 2018-10-30 Academia Sinica Collector architecture layout design
US10107726B2 (en) 2016-03-16 2018-10-23 Cellmax, Ltd. Collection of suspended cells using a transferable membrane
US10605708B2 (en) 2016-03-16 2020-03-31 Cellmax, Ltd Collection of suspended cells using a transferable membrane

Also Published As

Publication number Publication date
WO2005061075A1 (en) 2005-07-07
US20040118757A1 (en) 2004-06-24

Similar Documents

Publication Publication Date Title
US6890426B2 (en) Magnetic separation apparatus and methods
US6790366B2 (en) Magnetic separation apparatus and methods
US6660159B1 (en) Magnetic separation apparatus and methods
US5985153A (en) Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
US6136182A (en) Magnetic devices and sample chambers for examination and manipulation of cells
US7666308B2 (en) Magnetic separation apparatus and methods
US6623983B1 (en) Apparatus and methods for capture and analysis of particulate entities
WO1997046882A9 (en) Magnetic separation employing external and internal gradients
EP1144073B1 (en) Magnetic separation apparatus and methods
US7282180B2 (en) Devices and methods to image objects
US8189899B2 (en) Methods and algorithms for cell enumeration in a low-cost cytometer
US20060094109A1 (en) Device and method for analytical cell imaging
JP2005524833A (en) Devices and methods for analytical cell imaging
EP1356420B1 (en) Devices and methods to image objects
JP2007521495A (en) Method and device for splitting biological samples by magnetic effect
JPH0843378A (en) Method and equipment for magnetic cell measurement
CA2533683C (en) Magnetic separation apparatus and methods
JP4593672B2 (en) Magnetic separator and method thereof
AU2002245215A1 (en) Devices and methods to image objects

Legal Events

Date Code Title Description
AS Assignment

Owner name: IMMUNIVEST CORPORATION, DELAWARE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TERSTAPPEN, LEON W.M.M.;DOLAN, GERALD;REEL/FRAME:014813/0299;SIGNING DATES FROM 20010523 TO 20030304

STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: VERIDEX, LLC, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IMMUNICON CORP.;REEL/FRAME:021334/0454

Effective date: 20080731

Owner name: VERIDEX, LLC,NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IMMUNICON CORP.;REEL/FRAME:021334/0454

Effective date: 20080731

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: JANSSEN DIAGNOSTICS, LLC, NEW JERSEY

Free format text: CHANGE OF NAME;ASSIGNOR:VERIDEX, LLC;REEL/FRAME:031970/0554

Effective date: 20130528

FPAY Fee payment

Year of fee payment: 12